Asclepius Growth Capital

Asclepius Ventures is a healthcare-focused venture capital firm commercializing proven healthcare technologies. It provides deep industry expertise and strategic guidance to innovative, early-stage companies. The firm partners with entrepreneurs to scale technology-driven solutions that reduce costs, improve clinical outcomes, and transform care delivery, targeting businesses with validated solutions and strong revenue traction.

David Jahns leads Asclepius Ventures, also Managing Partner at Galen Partners. This leadership applies significant experience in healthcare investment, identifying and nurturing promising ventures. The firm’s genesis stems from the belief that scalable technology with disciplined execution is paramount for transforming healthcare at scale.

Asclepius Ventures collaborates with early-stage healthcare companies, benefiting patients, providers, and payers. Its vision accelerates next-generation healthcare solutions, shaping the future through aligning capital with mission-driven innovation. The firm cultivates purpose-driven cultures, ensuring lasting value across the healthcare ecosystem.